Beyond Infliximab: Other Anti-TNF Therapies for Ulcerative Colitis
Clinical trials ACT1/ACT2 ULTRA1/ULTRA2 PURSUIT-SC Placebo (n = 121/123) IFX 5 mg/kg (n = 121/121) IFX 10 mg/kg (n = 122/120) Placebo (n = 130/246) ADA 80/40 (n = 130/–) ADA 160/80 (n = 130/248) Placebo (n = 331) GLM 100/50 (n = 72) GLM 200/100…